Not Losing Weight on Mounjaro 10mg? What's Actually Going On

You've been on 10mg for weeks and the scales haven't moved

Picture this: you moved up to 10mg, felt the dose working (less hunger, earlier fullness) and then, after a few weeks, the weight simply stopped dropping. The number on the scale sits stubbornly in place. It's one of the questions our prescribers hear most weeks, and the frustration is real.

The first thing worth knowing is that a plateau is not the same as treatment failure. When the body loses weight, it defends itself. Resting metabolic rate falls, hunger hormones shift, and the calorie gap that was producing loss gradually narrows. This is a normal physiological response, not a sign that Mounjaro has stopped working. The NHS tirzepatide guidance acknowledges that weight loss is not continuous throughout treatment.

At 10mg specifically, some people are still mid-titration, they haven't yet reached the highest dose their prescriber considers appropriate. SURMOUNT-1 trial data, published in the New England Journal of Medicine, found meaningfully greater average weight reduction at 15mg than at 10mg, which tells us that dose adequacy matters. If you haven't yet explored what happens at the 12.5mg step, that context may be useful. Whether moving up is right for you is a clinical decision, not a self-service one.

Timing also matters. The body often needs six to eight weeks at a steady dose before a meaningful signal appears, and if you hit a similar wall earlier in your treatment, our guide on stalling at 5mg explains why that pattern is so common. A three-week plateau at 10mg is not the same as a three-month one.

The things that quietly work against weight loss on 10mg

Mounjaro reduces appetite, but it does not override everything. Several factors can blunt weight loss even when the medicine is doing its job correctly.

Calorie creep. Reduced hunger can make people less vigilant about portion sizes, not more. A few hundred extra calories per day (easily arrived at through liquid calories, snacks eaten absent-mindedly, or richer food choices) can close the deficit Mounjaro opened. Keeping a rough food log for a week often reveals gaps people weren't aware of.

Protein and muscle. Significant weight loss on any treatment includes some muscle loss alongside fat. Inadequate protein intake accelerates this, and less muscle means a lower metabolic rate. Eating enough protein (broadly 1.2–1.6g per kg of body weight per day, though a dietitian can personalise this) helps preserve lean mass and supports ongoing loss.

Sleep and stress. Cortisol released during poor sleep or sustained stress raises blood glucose and promotes fat storage around the abdomen. Research links short sleep duration with higher appetite and lower satiety, counteracting some of what tirzepatide is doing. These aren't soft lifestyle factors; they are physiological ones.

Other medicines. Certain antidepressants, antipsychotics, corticosteroids, and beta-blockers are associated with weight gain or weight-loss resistance. If you started one of these around the time your progress stalled, mention it to your prescriber.

It is also worth gently setting aside one common misconception: that switching injection site or technique could meaningfully change how much weight you lose. Correct technique matters for absorption consistency, but rotating sites does not produce more weight loss, the dose does.

What your prescriber looks at when progress stalls on 10mg

At every repeat review, a prescriber considers whether the current dose is still the right one. At nume (sorry, at a service like this) that review is done by a real clinician, not automated software. For patients not losing weight on 10mg Mounjaro, the conversation typically covers several things.

First: how long has the plateau lasted? A genuine stall lasting more than eight weeks at a stable dose, with no obvious dietary or lifestyle explanation, is clinically meaningful. Second: has the highest tolerated dose been reached? If 10mg is being well-tolerated, moving to 12.5mg (and potentially to the 15mg ceiling dose) is often the next clinical step. Third: are there any concurrent health conditions or medicines that need to be accounted for?

The NICE guidance on tirzepatide (TA1026) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That six-month window at maximum tolerated dose is the relevant benchmark, not six months across all doses.

If you're weighing up cost alongside effectiveness (whether it's worth continuing or adjusting) our Mounjaro cost page sets out what private treatment includes and how pricing works. And if you want to understand how this dose compares to the full treatment journey, the Mounjaro treatment overview covers the whole picture.

When to speak to someone

A plateau is rarely urgent, but there are situations where you should contact your prescriber sooner rather than later. If weight loss has stopped and you have also noticed new symptoms (persistent nausea, abdominal discomfort, or feeling unwell beyond what you'd expect) get in touch. Side effects that were manageable at lower doses can intensify at 10mg for some people, and a prescriber needs to know.

If you are wondering whether the 10mg dose is right for your situation, or what a treatment plan looks like longer term, a maintenance plan conversation is a good place to start. For general questions before reaching out, our FAQs cover a range of common treatment queries.

Plateaus are part of the biology of weight loss. They are not a verdict on whether Mounjaro is working for you. If you'd like a prescriber to look at your progress properly, check your eligibility for a free consultation.